Clinical utility of PET/CT with 18F-FSU-880 for recurrent prostate cancer
Phase 2
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000034190
- Lead Sponsor
- Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 74
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients having severe communication problem. 2. Patients with severe general condition. 3. Patients having severe renal dysfunction (eGFR<39mL/min/1.73m3) expected to affect the distribution of [18F]FSU-880.. 4. Patients to whom participating physicians judged to be inappropriate for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method presence or absence of abnormal uptake of FSU-880
- Secondary Outcome Measures
Name Time Method Time course of uptake and/or tumor-to-background ratio in a lesion